Top Tweets for #16icml

over 4 years ago

👀Have you seen this? At the #16ICML @lymphomahub spoke with @ccarlostella, @HumanitasMilano. We asked, How does step-up dosing compare with fixed dosing for glofitamab in R/R non-Hodgkin #lymphoma (#NHL)? 👉 https://t.co/t8eRyknN4d 👈 #lymsm

lymphomahub's tweet photo. 👀Have you seen this?

At the #16ICML @lymphomahub spoke with @ccarlostella, @HumanitasMilano. We asked, How does step-up dosing compare with fixed dosing for glofitamab in R/R non-Hodgkin #lymphoma (#NHL)?

👉 https://t.co/t8eRyknN4d 👈

#lymsm https://t.co/iWDVZbWYpg

0

2

1

0

over 4 years ago

👀 Did you see this? The Lymphoma Hub Satellite Symposium, which discussed sequencing of therapies in high-risk R/R #lymphoma and #CLL, was a great success! 🙌 You can view all the content on the Lymphoma Hub: 👉 https://t.co/dmrPMjcbpr 👈 #LymHubSS #16ICML #lymsm #leusm

lymphomahub's tweet photo. 👀 Did you see this?

The Lymphoma Hub Satellite Symposium, which discussed sequencing of therapies in high-risk R/R #lymphoma and #CLL, was a great success! 🙌

You can view all the content on the Lymphoma Hub:
👉 https://t.co/dmrPMjcbpr 👈

#LymHubSS #16ICML #lymsm #leusm https://t.co/28RwhKj10i

0

6

4

1

0

SSBMT الخلاياالجذعية

@SSBMT

almost 5 years ago

Riad Elfakih presenting the abstract of #Tisa_cel #CarTcell in r/r Follicular #lymphoma (ELARA trial) #icml2021 #16ICML #ICML16 #ssbmt #lymsm #SaudiHematology 21 #SaudiLymphoma 21 #Saudi_Lymphoma_Group

SSBMT's tweet photo. Riad Elfakih presenting the abstract of #Tisa_cel #CarTcell in r/r Follicular #lymphoma (ELARA trial)
#icml2021 #16ICML #ICML16 #ssbmt #lymsm
#SaudiHematology 21
#SaudiLymphoma 21
#Saudi_Lymphoma_Group https://t.co/diJJWWqP1F

0

2

0

SSBMT الخلاياالجذعية

@SSBMT

almost 5 years ago

Musa Alzahrani presenting the abstract of combination of venetoclax, Lenalidomide and Rituximab in newly diagnosed mantle cell #lymphoma #icml2021 #16ICML #ICML16 #ssbmt #lymsm #SaudiHematology 21 #SaudiLymphoma 21 #Saudi_Lymphoma_Group

SSBMT's tweet photo. Musa Alzahrani presenting the abstract of combination of venetoclax, Lenalidomide and Rituximab in newly diagnosed mantle cell #lymphoma
#icml2021 #16ICML #ICML16 #ssbmt #lymsm
#SaudiHematology 21
#SaudiLymphoma 21
#Saudi_Lymphoma_Group https://t.co/6MZCAuZOrc

0

3

1

0

SSBMT الخلاياالجذعية

@SSBMT

almost 5 years ago

Emanuele Zucca presenting MATRix chemotherapy for CNS #lymphoma followed by whole brain radiation or auto-HSCT #icml2021 #16ICML #ICML16 #SaudiHematology 21 #SaudiLymphoma 21 #ssbmt #lymsm #Saudi_Lymphoma_Group

SSBMT's tweet photo. Emanuele Zucca presenting MATRix chemotherapy for CNS #lymphoma followed by whole brain radiation or auto-HSCT
#icml2021 #16ICML #ICML16
#SaudiHematology 21
#SaudiLymphoma 21
#ssbmt #lymsm #Saudi_Lymphoma_Group https://t.co/RpBnfSpUaf

0

2

0

about 5 years ago

Phase II Geltamo IMCL-2015: ibrutinib and rituximab in indolent #MantleCellLymphoma Eva Giné of @hospitalclinic shares findings: https://t.co/lTZCM9Dsb0 #16ICML @icmlugano #HemOnc #Lymphoma #Lymsm #CTSM #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

0

1

0

about 5 years ago

Simone Ferrero (@unito) talks on the Phase III MCL0208 trial of len vs. observation after rituximab induction for #MantleCellLymphoma Genomic prognostic factors with significant impact on PFS identified: https://t.co/xVxYhh4BjO #16ICML @icmlugano #HemOnc #Lymphoma #Lymsm #BCAM

0

2

0

about 5 years ago

TRANSCEND-CLL-004: liso-cel in #CLL w/ @wwierda (@MDAndersonNews): https://t.co/ncuBAMyE5L #16ICML @icmlugano #HemOnc #CLLsm #Leusm #CTSM #TrialUpdate #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

0

8

0

AACR @AACR

about 5 years ago

September is Leukemia and Lymphoma Awareness Month. Learn about the potential uses for artificial intelligence in lymphoma research and treatment on the #AACRBlog: https://t.co/mmSVOyj8oF #16ICML

0

8

3

0

about 5 years ago

🎧 Listen to this #16ICML podcast with Laurie Sehn, @UBC and Grzegorz Nowakowski, @MayoClinic. We asked, Is frontline R-CHOP still the standard of care for DLBCL? 👉 https://t.co/5Qo1YHBnOq 👈 #lymsm #lymphoma

lymphomahub's tweet photo. 🎧 Listen to this #16ICML podcast with Laurie Sehn, @UBC and Grzegorz Nowakowski, @MayoClinic. We asked, Is frontline R-CHOP still the standard of care for DLBCL?

👉 https://t.co/5Qo1YHBnOq 👈

#lymsm #lymphoma https://t.co/p8P9QQFie3

0

3

1

0

about 5 years ago

📚 @KRejeski recently presented at #16ICML and published in @bloodjournal the CAR-HEMATOTOX model to predict severe neutropenia following CAR T cell therapy for #LBCL 👉 https://t.co/elTN6654ET 👈 #lymsm #lymphoma

0

5

1

0

BioAscend

@BioAscend

about 5 years ago

There is still time! CLICK HERE: https://t.co/xBjX5BpNRK to join us in 10 minutes and tune in live at our Virtual Challenging Case Clinic™ - Get the latest updates from #ASCO21, #EHA21 & #16ICML with @JohnPLeonardMD & @gilles_salles #lymphoma

BioAscend's tweet photo. There is still time! CLICK HERE: https://t.co/xBjX5BpNRK to join us in 10 minutes and tune in live at our Virtual Challenging Case Clinic™ - Get the latest updates from #ASCO21, #EHA21 & #16ICML with @JohnPLeonardMD & @gilles_salles #lymphoma https://t.co/UM9rlFT2vt

0

2

0

about 5 years ago

👀 During #16ICML the @lymphomahub spoke with Martin Dreyling, @LMU_Muenchen. We asked, What’s new in mantle cell lymphoma? 👉 https://t.co/pcKMz112ww 👈 #lymsm #lymphoma

lymphomahub's tweet photo. 👀 During #16ICML the @lymphomahub spoke with Martin Dreyling, @LMU_Muenchen. We asked, What’s new in mantle cell lymphoma?

👉 https://t.co/pcKMz112ww 👈

#lymsm #lymphoma https://t.co/cypsklZvoa

0

4

0

1

0

about 5 years ago

👀 During #16ICML, @lymphomahub spoke with Steven Horowitz, @sloan_kettering. We asked, Does the addition of romidepsin to duvelisib enhance tumor responses in peripheral T-cell lymphoma? 👉https://t.co/Wt9bcAfxBx 👈 #lymsm #lymphoma #hemonc

lymphomahub's tweet photo. 👀 During #16ICML, @lymphomahub spoke with Steven Horowitz, @sloan_kettering. We asked, Does the addition of romidepsin to duvelisib enhance tumor responses in peripheral T-cell lymphoma?

👉https://t.co/Wt9bcAfxBx 👈

#lymsm #lymphoma #hemonc https://t.co/WHa588Qp6i

0

3

1

0

about 5 years ago

Not long until our post-EHA/ICML #LymphomaSession with @gilles_salles @niravshahmd Ulrich Jäger and Stephen Ansell! 🗓 Thurs 29 July at 7pm CEST/6pm BST/1pm EDT📊 Don’t miss your chance to register: https://t.co/4amTZ8Tzdg @VJHemOnc #VJSessions #Lymsm #Lymphoma #EHA21 #16ICML

VJHemOnc's tweet photo. Not long until our post-EHA/ICML #LymphomaSession with @gilles_salles @niravshahmd Ulrich Jäger and Stephen Ansell!

🗓 Thurs 29 July at 7pm CEST/6pm BST/1pm EDT📊

Don’t miss your chance to register: https://t.co/4amTZ8Tzdg

@VJHemOnc #VJSessions #Lymsm #Lymphoma #EHA21 #16ICML https://t.co/mJ3RP6XURb

0

2

1

0

International Conference on Malignant Lymphoma @icmlugano

about 5 years ago

Not long until our post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥 🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊 Don’t miss your chance to register: https://t.co/dGYhcIKwgd @VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML

VJHemOnc's tweet photo. Not long until our post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥

🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊

Don’t miss your chance to register: https://t.co/dGYhcIKwgd

@VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML https://t.co/PeFP53Jqiu

0

3

0

about 5 years ago

⏪ Did you miss the #16ICML? Good news: you can access the Congress materials on-demand and enjoy the 16-ICML anytime you wish until July 11, 2022! 🔗Discover more: https://t.co/cUJ0Vow5SG

0

2

1

0

about 5 years ago

🎧 #16ICML | @lymphomahub spoke with Björn Chapuy, Universitätsmedizin Göttingen, and Leticia Quintanilla-Martinez de Fend, @uktuebingen. We asked, What is the role of genetic classification in the diagnosis of #DLBCL 👉 https://t.co/LNGI1lo2IY 👈 #lymsm #lymphoma

lymphomahub's tweet photo. 🎧 #16ICML | @lymphomahub spoke with Björn Chapuy, Universitätsmedizin Göttingen, and Leticia Quintanilla-Martinez de Fend, @uktuebingen. We asked, What is the role of genetic classification in the diagnosis of #DLBCL

👉 https://t.co/LNGI1lo2IY 👈

#lymsm #lymphoma https://t.co/vVmyXqyM5k

0

1

0